login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
PELTHOS THERAPEUTICS INC (PTHS) Stock News
USA
- NYSEARCA:PTHS -
US1711262048
-
Common Stock
26.395
USD
-1.39 (-5.02%)
Last: 10/8/2025, 3:51:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PTHS Latest News, Press Relases and Analysis
All
Press Releases
22 days ago - By: ACCESS Newswire
- Mentions:
UXIN
JG
PRSO
SPCB
...
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
a month ago - By: Pelthos Therapeutics, Inc.
Pelthos Therapeutics to Participate in Upcoming September Investor Conferences
a month ago - By: Benzinga
- Mentions:
AEMD
CSCI
ALTS
WVE
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
2 months ago - By: Pelthos Therapeutics, Inc.
Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update
3 months ago - By: Benzinga
- Mentions:
CALC
KPTI
CAPR
ATHE
...
12 Health Care Stocks Moving In Friday's Intraday Session
3 months ago - By: Stocktwits
- Mentions:
LGND
Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts
3 months ago - By: Channel Therapeutics Corporation
- Mentions:
CHRO
Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
Please enable JavaScript to continue using this application.